327. 特発性血栓症(遺伝性血栓性素因によるものに限る。) Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 3 / 薬物数 : 13 - (DrugBank : 3) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 1
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Clexane
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Clexane/lovenox
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Dalteparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Fragmin
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Innohep
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Tinzaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Clexane/lovenox
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Dalteparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Fragmin
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Innohep
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Tinzaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
